Dr. David Schanzlin First to Use EK Injector for Corneal Transplant During Endothelial Keratoplasty

Gordon-Weiss-Schanzlin Vision Institute in San Diego announced that its eye surgeon, David J. Schanzlin, MD, recently performed the first corneal transplant during endothelial keratoplasty surgery using the new EK Injector from TDAK Medical.

The FDA-approved device was developed as a result of a collaboration between TDAK Medical CEO Tom Trozera, Dr. Schanzlin and several physicians at the University of California San Diego.

According to Dr. Schanzlin, who also serves as president of the San Diego Eye Bank, the EK Injector minimizes the surgeon's time in the eye during endothelial keratoplasty surgery, significantly reduces the loss of endothelial cells during surgery and simplifies the eye bank's process for handling the tissue.

More Articles on Supply Chain:

Reducing Supply Chain Costs
First Navio Unicondylar Knee Replacement Performed in France
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers